🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523284-37-00
Completed Phase II

CHARACTERIZATION OF ASTROCYTE REACTIVITY WITH [18F]F-DED PET IN NEURODEGENERATIVE DISEASES

2025-523284-37-00 · tracked via the Priya Life Science EU tracker
Sponsor
Barcelonabeta Brain Research Center
Sponsor type
Laboratory/Research/Testing facility
Therapeutic area
Nervous System Diseases
Decision date
24/03/2026
Enrollment target
300
Sites
Spain

Condition studied

Dementia, Autosomal Dominant Alzheimer's Disease, Sporadic early onset Alzheimer Disease, Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Late onset Alzheimer Disease

Investigational medicinal product(s)

[18F]DED

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male

Primary endpoint

Non Applicable

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523284-37-00 on CTIS ↗ ← All trials in the EU